Navigation Links
Mylan Confirms First-to-File Patent Challenge Relating to Vytorin(R) Cholesterol Medication
Date:12/22/2009

PITTSBURGH, Dec. 22 /PRNewswire-FirstCall/ -- Mylan Inc. (Nasdaq: MYL) today confirmed that the company and its subsidiary Mylan Pharmaceuticals Inc. have been sued by Schering Corporation and MSP Singapore Company in connection with the filing of an Abbreviated New Drug Application (ANDA) with the U.S. Food and Drug Administration (FDA) for Ezetimibe and Simvastatin Tablets, 10 mg/10 mg, 10 mg/20 mg, 10 mg/40 mg and 10 mg/80 mg. This product is the generic version of Vytorin® Tablets, a cholesterol treatment.

Mylan believes it is the first company to have filed a substantially complete ANDA containing a Paragraph IV certification for the product and expects to qualify for 180 days of sole marketing exclusivity once final FDA approval is obtained. Schering and MSP Singapore filed a lawsuit Dec. 16 in the U.S. District Court for the District of New Jersey alleging patent infringement.

Vytorin Tablets had approximately $1.6 billion in sales for the same strengths for the 12 months ending Sept. 30, according to IMS Health. Currently, Mylan has 133 ANDAs pending FDA approval representing $85.6 billion in annual brand sales, according to IMS. Thirty-eight of these pending ANDAs are potential first-to-file opportunities, representing $19.3 billion in annual brand sales, according to IMS.

This press release includes statements that constitute "forward-looking statements," including with regard to the expected first-to-file status and pending litigation. These statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. Because such statements inherently involve risks and uncertainties, actual future results may differ materially from those expressed or implied by such forward-looking statements. Factors that could cause or contribute to such differences
'/>"/>

SOURCE Mylan Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Mylan Announces Settlement Agreement Related to Antidepressant Effexor XR(R)
2. Mylan Receives FDA Approval for Generic Version of Parkinsons Treatment Sinemet(R)
3. Mylan Schedules Third Quarter 2009 Financial Results Conference Call and Live Webcast
4. Mylan Receives FDA Approval for Generic Version of Anticonvulsant Topamax(R) Sprinkle Capsules
5. Mylans President of Europe, Middle East and Africa Elected President of European Generic Medicines Association
6. Mylan Receives Tentative FDA Approval Under PEPFAR for Matrix Laboratories New Drug Application (NDA) for Efavirenz Tablets
7. Mylan Added to NASDAQ-100 Index
8. Mylan Receives Approval for Generic Version of Antiepileptic Keppra(R) 1000 mg
9. Study Confirms Limited Human-To-Human Spread of Avian-Flu Virus in Indonesia in 2006
10. IDM Pharma Announces Updated Phase 3 Mifamurtide (L-MTP-PE) Data Confirms Statistically Superior Overall Survival in Osteosarcoma Patients
11. Study Confirms That New Protocol Shortens the Time It Takes to Open Blocked Arteries for Heart Attack Patients
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/22/2014)... N.J. , Nov. 21, 2014  CytoSorbents ... commercializing its European Union approved CytoSorb® cytokine adsorber ... was awarded the Beacon of Light Award at ... Celebration.  Dr. Phillip Chan ... is an honor to be recognized by the ...
(Date:11/22/2014)... , Nov. 21, 2014 Statistics released ... and drunk driving increase astronomically during the holidays, beginning ... in many cities. The data, ... Monitoring Systems as part of their annual ... paints a picture of high-risk drinking and increased rates ...
(Date:11/22/2014)... , Nov. 21, 2014 Research and Markets ... Protein Drug Industry Report, 2014-2017" report to their ... The Chinese recombinant protein drug market has been ... consumption ability and the like. During 2005-2013, sales of ... at a CAGR of 19.1%, and it is projected ...
Breaking Medicine Technology:CytoSorbents Wins Beacon of Light Award 2CytoSorbents Wins Beacon of Light Award 3CytoSorbents Wins Beacon of Light Award 4Alarming Stats Show Holiday Drinking an Issue for Many 2China Recombinant Protein Drug Industry Report, 2014-2017 2China Recombinant Protein Drug Industry Report, 2014-2017 3
... PITTSBURGH, Nov. 9, 2011 Mylan Inc. (Nasdaq: ... has entered into an agreement with Pfizer for ... commercialize Pfizer,s generic equivalent to GlaxoSmithKline,s Advair® Diskus ... inhaler delivery platform. Advair® Diskus and Seretide® Diskus ...
... Nov. 9, 2011 LCA-Vision Inc. (NASDAQ: LCAV ... the Lasik Plus ® brand, today announced that management will ... on Wednesday, November 16, 2011, at 11:00 a.m. Eastern time. ... New York City.  A live and archived webcast of the ...
Cached Medicine Technology:Mylan to Acquire Pfizer Respiratory Delivery Platform 2Mylan to Acquire Pfizer Respiratory Delivery Platform 3Mylan to Acquire Pfizer Respiratory Delivery Platform 4
(Date:11/22/2014)... November 22, 2014 In order to provide ... promotion of cocktail party dresses. The business knows that a ... social occasions. , Now, the party dresses supplier’s ... 70% off. As the leading company in fashion industry, LunaDress ... outfit for every customer. So it always raises the professional ...
(Date:11/22/2014)... November 22, 2014 "My friend went ... caused by the machine," said an inventor from Cambria ... to go back a second time because the first ... , She developed the patent-pending MAMO EASY to offer ... The design saves the patient from the pain normally ...
(Date:11/22/2014)... 22, 2014 Domestic farmgate milk ... in 2009-10, due to a fall in demand ... industry products amid the global financial crisis. However, ... of Australian dairy manufacturers on the international scene. ... outweighed supply growth, primarily due to supply constraints ...
(Date:11/22/2014)... Everett, WA (PRWEB) November 22, 2014 The ... beauty and complexity of block retaining walls. The article states ... strength, there are several necessary steps that go into creating ... steps when building a retaining wall is choosing which kind ... desired purpose. , B&D Rockeries says, “The two main ...
(Date:11/22/2014)... This month has been a historical time for Angeldress.co.uk, an ... reviews from some renowned review websites. Recently, the company has ... new selection of wonderful sexy wedding dresses to its website. ... and up to an 80% discount on any order over ... most suitable dress at Angeldress.co.uk, which has garnered a hard ...
Breaking Medicine News(10 mins):Health News:LunaDress Unveils Fabulous Cocktail Party Dresses 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 2Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 3Health News:Butter and Dairy Product Manufacturing in Australia Industry Market Research Report Now Updated by IBISWorld 4Health News:5 Step Installment of Block Retaining Walls is Topic of Latest Article by B&D Rockeries 2Health News:Sexy Wedding Dresses with Special Discounts Launched by Angeldress.co.uk 2
... worry about the extra, and often burdensome, responsibilities which ... to evidence to be presented at a major two-day ... field of genomics, funded by the Economic and Social ... Todays Answers, Tomorrows Questions is taking place in ...
... Losing a limb at age 18 would,devastate even ... some plastic surgery patients are able turn their ... need. Scott Rigsby and three,other such reconstructive plastic ... Courage: Triumph Over Adversity award at the American ...
... Inc. (Nasdaq: COLY ), today announced that the ... Eastern Time on November,1, 2007 to discuss second quarter ... broadcast or the subsequent archived recording,of the call, please ... http://www.coleypharma.com . Please log onto Coley,s website several,minutes ...
... of Wisconsin ... ... ENDO ), an innovative medical device company focused on the,development of ... tumor ablation, announced today,that a new five-year retrospective study published in ...
... SYDNEY, Australia, Oct. 24 The 5th site in ... A to Z of,Materials, AZoNano.com - the A to ... of Building. AZoOptics.com ( http://www.AZoOptics.com ) is the ... the global optics,photonics, semiconductor, science, design and engineering community ...
... United,America Indemnity, Ltd. (Nasdaq: INDM ) today ... also announced that its Board of Directors has,authorized the ... Company,s common,shares through a share repurchase program. (Logo: ... for the third quarter 2007 included: -- A ...
Cached Medicine News:Health News:Public not so sure 'personalized medicine' 2Health News:Atlanta 'Ironman' Scott Rigsby Receives Award for Inspiration, Courage 2Health News:Coley Pharmaceutical Group to Report Third Quarter Results on November 1, 2007 2Health News:New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer 2Health News:New Study Data Published in British Journal of Urology Demonstrates Cryoablation Effective for Kidney Cancer 3Health News:AZoOptics.com - The A to Z of Optics Launched By AZoNetwork 2Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 2Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 3Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 4Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 5Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 6Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 7Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 8Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 9Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 10Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 11Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 12Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 13Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 14Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 15Health News:United America Indemnity, Ltd. Reports Third Quarter 2007 Results and Share Repurchase Program 16
Subretinal Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 3mm, 32g (0.23); Angled at 35°....
Silicone Oil Cannula; 16g (1.40) x 8mm....
Injection Cannula, Straight; 20g (0.90) x 1" (25mm); Tip Extension: 5mm, 30g (0.30)....
...
Medicine Products: